ObesityNovo Nordisk funds API manufacturing with €726mLatest NewsNovo Nordisk A/S invests €726m to expand facilities and to produce APIs to supply the company’s global clinical trials. Read more 30 November 2022 https://european-biotechnology.com/wp-content/uploads/2024/04/_c__DarkoStokanovic_pixabay.com.jpg 640 960 Margarita Milidakis /wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.png Margarita Milidakis2022-11-30 16:09:122024-07-16 12:11:18Novo Nordisk funds API manufacturing with €726m